Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL28046398

CC(C)(C)OC=O.O[C@@H]1CNC[C@H]1c1ccc(F)cc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.41
SLC6A3 Q01959 6/20 0.35
SLC6A4 P31645 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
KDM1A O60341 4/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HTR2C P28335 3/20 0.33
SLC6A2 P23975 2/20 0.33
HTR2A P28223 2/20 0.33
HTR2B P41595 2/20 0.33
FPR1 P21462 1/20 0.32
FPR2 P25090 1/20 0.32
DRD2 P14416 1/20 0.32
OPRM1 P35372 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27970141 0.88 GRK2 (0.40) TACR1SLC6A3SLC6A4TDP1SLC6A2
Tert-Butyl Formate SCHEMBL27970142 0.88 GRK2 (0.40) TACR1SLC6A3SLC6A4TDP1SLC6A2
SCHEMBL2146401 0.82 KDM1A (0.45) TACR1SLC6A3SLC6A4KDM1AHTR2C
SCHEMBL16031350 0.82 KDM1A (0.45) TACR1SLC6A3SLC6A4KDM1AHTR2C
SCHEMBL2146399 0.82 KDM1A (0.45) TACR1SLC6A3SLC6A4KDM1AHTR2C
SCHEMBL16031353 0.82 KDM1A (0.45) TACR1SLC6A3SLC6A4KDM1AHTR2C
Tert-Butyl Formate SCHEMBL27970029 0.78 GRK2 (0.40) TACR1SLC6A3SLC6A4TDP1SLC6A2
Tert-Butyl Formate SCHEMBL27970027 0.78 GRK2 (0.40) TACR1SLC6A3SLC6A4TDP1SLC6A2
Tert-Butyl Formate SCHEMBL27412204 0.77 TDP1 (0.54) TDP1
Tert-Butyl Formate SCHEMBL27412203 0.77 TDP1 (0.54) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105209457-A Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy ABBVIE DEUTSCHLAND 2015-12-30 CN disclosed